» Articles » PMID: 32256598

Antiaging Factor Klotho Retards the Progress of Intervertebral Disc Degeneration Through the Toll-Like Receptor 4-NF-B Pathway

Overview
Journal Int J Cell Biol
Publisher Wiley
Specialty Cell Biology
Date 2020 Apr 8
PMID 32256598
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Antiaging protein Klotho exhibits impressive properties of anti-inflammation, however is declined early after intervertebral disc injury, making Klotho restoration an attractive strategy of treating intervertebral disc inflammatory disorders. Here, we have found that Klotho is enriched in nucleus pulposus (NP) cells and Klotho overexpression attenuates HO-induced acute inflammation essentially via suppressing Toll-like receptor 4 (TLR4). The proinflammatory NF-B signaling and cytokine expressions paralleled with Klotho repression and TLR4 elevation in both NP cells (HO treatment) and rat intervertebral disc (needle puncture treatment). Overexpression of TLR4 downregulated expression of Klotho, whereas interfering TLR4 expression diminished the inhibitory effects of HO on Klotho in NP cells. Consistently, Klotho knockdown by RNA interferences largely diminished the anti-inflammatory and intervertebral disc protective effects in an Intervertebral Disc Degeneration (IDD) model. Thus, our study indicates that TLR4-NF-B signaling and Klotho form a negative-feedback loop in NP cells. Also, we demonstrate that the expression of Klotho is regulated by the balance between upregulation and downregulation of TLR4-NF-B signaling.

Citing Articles

Targeting skeletal interoception: a novel mechanistic insight into intervertebral disc degeneration and pain management.

Zhu H, Ren J, Wang X, Qin W, Xie Y J Orthop Surg Res. 2025; 20(1):159.

PMID: 39940003 PMC: 11823264. DOI: 10.1186/s13018-025-05577-7.


Klotho mutation does not accelerate intervertebral disc aging in mice.

Hong J, Shah V, Krishnan R, Gomez-Stallons M, Poudel S, Yutzey K FASEB J. 2025; 39(1):e70279.

PMID: 39760159 PMC: 11701877. DOI: 10.1096/fj.202402847R.


New insights into the role of Klotho in inflammation and fibrosis: molecular and cellular mechanisms.

Zhao X, Han D, Zhao C, Yang F, Wang Z, Gao Y Front Immunol. 2024; 15:1454142.

PMID: 39308872 PMC: 11412887. DOI: 10.3389/fimmu.2024.1454142.


Anti-Inflammatory Role of the Klotho Protein and Relevance to Aging.

Prudhomme G, Wang Q Cells. 2024; 13(17.

PMID: 39272986 PMC: 11394293. DOI: 10.3390/cells13171413.


Current Therapeutic Strategies of Intervertebral Disc Regenerative Medicine.

Elmounedi N, Bahloul W, Keskes H Mol Diagn Ther. 2024; 28(6):745-775.

PMID: 39158834 DOI: 10.1007/s40291-024-00729-7.


References
1.
Weber K, Alipui D, Sison C, Bloom O, Quraishi S, Overby M . Serum levels of the proinflammatory cytokine interleukin-6 vary based on diagnoses in individuals with lumbar intervertebral disc diseases. Arthritis Res Ther. 2016; 18:3. PMC: 4718017. DOI: 10.1186/s13075-015-0887-8. View

2.
Yamada Y, Ando F, Niino N, Shimokata H . Association of polymorphisms of the androgen receptor and klotho genes with bone mineral density in Japanese women. J Mol Med (Berl). 2004; 83(1):50-7. DOI: 10.1007/s00109-004-0578-4. View

3.
Doi S, Zou Y, Togao O, Pastor J, John G, Wang L . Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem. 2011; 286(10):8655-8665. PMC: 3048747. DOI: 10.1074/jbc.M110.174037. View

4.
Phillips K, Jordan-Mahy N, Nicklin M, Le Maitre C . Interleukin-1 receptor antagonist deficient mice provide insights into pathogenesis of human intervertebral disc degeneration. Ann Rheum Dis. 2013; 72(11):1860-7. DOI: 10.1136/annrheumdis-2012-202266. View

5.
Ben-Dov I, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-O M, Mohammadi M . The parathyroid is a target organ for FGF23 in rats. J Clin Invest. 2007; 117(12):4003-8. PMC: 2066196. DOI: 10.1172/JCI32409. View